Sunday, March 15, 2020 10:18:54 AM
LH in the NEWS getting free pub as TESTING becomes the coronavirus mantra... & first line of defense (since no vaccine is expected for 18mos).
Walgreens to add 600 LabCorp "tuck-in" locations:
Walgreens and LabCorp to Open at Least 600 LabCorp at Walgreens
Strategic collaboration reflects both companies’ focus on providing customers access to affordable in-store health care services
DEERFIELD, Ill. and BURLINGTON, N.C. — Walgreens and LabCorp® (NYSE: LH) today announced their mutual commitment to a significant expansion of their LabCorp at Walgreens collaboration. The two companies have agreed to open at least 600 LabCorp patient service centers at Walgreens stores across the U.S. over the next four years, inclusive of the 17 locations that have opened since they first announced their consumer-focused initiative in June 2017.
LabCorp at Walgreens locations are currently open in Florida, Colorado, North Carolina and Deerfield, Illinois, serving as an important part of LabCorp’s network of nearly 2,000 patient service centers across the U.S. Consumers and healthcare providers continue to have a positive response to the existing locations, which offer specimen collection services for LabCorp testing in a secure, comfortable environment. The sites are located near the pharmacy area inside the Walgreens store, providing a convenient location for consumers to access important health services and information.
“LabCorp’s strong partnership on this joint initiative, coupled with the enthusiastic consumer feedback we’ve received, allows us to undertake an exciting expansion of our collaboration together,” said Stefano Pessina, executive vice chairman and CEO of Walgreens Boots Alliance, Inc. “This reflects our commitment to transform our stores into neighborhood health destinations that provide a differentiated, consumer-focused experience, while providing access to a broad range of affordable health care services at a trusted and convenient setting.”
“We chose a partner with shared values and a shared vision of creating a differentiated consumer-focused experience, which has led to an extremely successful collaboration,” said David P. King, LabCorp’s chairman and CEO. “LabCorp at Walgreens is a central piece of our expanding consumer strategy, as we continue to create new channels for our offering by meeting consumers where they want to be met, extending the reach of our mission to improve health and improve lives.”
In addition, the companies are pursuing other collaboration opportunities, to take advantage of LabCorp’s unique combination of diagnostics and drug development expertise, and Walgreens leading experience in pharmacy, retail health and consumer engagement. The parties are exploring novel approaches to clinical research, helping consumers take a greater role in their own health and well-being, enabling the ongoing transition to value-based care, and expanding the health-related services available at LabCorp at Walgreens.
LabCorp at Walgreens locations offer collection of specimens for a broad range of laboratory testing that is performed in LabCorp’s nationwide network of regional and specialty laboratories. Appointments for all LabCorp at Walgreens locations may be made in advance at LabCorp.com/Walgreens, as well as through the LabCorp|Patient online portal and app, which is available for both Android and iOS. All locations feature the proprietary LabCorp|Express tablet-based system for expedited check-in.
Information about LabCorp at Walgreens, including locations, is available on Walgreens Find Care Now digital platform and marketplace that helps connect the company’s millions of mobile and online visitors to health care services at Walgreens stores.
About LabCorp
LabCorp (NYSE: LH), an S&P 500 company, is a leading global life sciences company that is deeply integrated in guiding patient care, providing comprehensive clinical laboratory and end-to-end drug development services. With a mission to improve health and improve lives, LabCorp delivers world-class diagnostic solutions, brings innovative medicines to patients faster and uses technology to improve the delivery of care. LabCorp reported net revenues of over $10 billion in 2017. To learn more about LabCorp, visit www.labcorp.com, and to learn more about Covance Drug Development, visit www.covance.com.
https://news.walgreens.com/press-releases/general-news/walgreens-and-labcorp-to-open-at-least-600-labcorp-at-walgreens-patient-service-centers.htm
Recent LH News
- Form PX14A6G - Notice of exempt solicitation submitted by non-management • Edgar (US Regulatory) • 05/06/2024 08:40:23 PM
- Labcorp Receives FDA Approval for First Companion Diagnostic for Use with Pfizer's Newly Approved Gene Therapy to Treat Patients with Hemophilia B • PR Newswire (US) • 04/29/2024 11:00:00 AM
- Labcorp Announces 2024 First Quarter Results • PR Newswire (US) • 04/25/2024 10:58:00 AM
- Labcorp Announces Winning Bid for Select Assets of Invitae • PR Newswire (US) • 04/25/2024 01:27:00 AM
- Invitae Enters into Agreement with Labcorp for Sale of Business • PR Newswire (US) • 04/25/2024 01:19:00 AM
- Labcorp Announces First-of-Its-Kind Test for Early Indication of Neurodegenerative Diseases and Brain Injuries Using a Blood Draw • PR Newswire (US) • 04/15/2024 11:00:00 AM
- Labcorp Declares Quarterly Dividend • PR Newswire (US) • 04/11/2024 10:59:00 AM
- Labcorp Receives FDA Emergency Use Authorization for Mpox PCR Test Home Collection Kit • PR Newswire (US) • 04/10/2024 10:49:00 AM
- Labcorp Announces Expansion of Precision Oncology Portfolio to Support Pharmaceutical, Biopharma, and Clinical Research in Advancing Drug Development Programs • PR Newswire (US) • 04/08/2024 11:00:00 AM
- Labcorp Launches Labcorp® Plasma Detect™ Extending Leadership into Molecular Residual Disease (MRD) Clinical Research • PR Newswire (US) • 04/05/2024 11:00:00 AM
- Labcorp to Present Diverse Portfolio of Precision Oncology Research at the Annual Meeting of the American Association for Cancer Research • PR Newswire (US) • 04/02/2024 11:00:00 AM
- Xcell Biosciences Strengthens Cell and Gene Therapy Collaboration With Labcorp • Business Wire • 04/01/2024 12:00:00 PM
- The Prelude Network® Names Labcorp Its Preferred Genetic Carrier Screening Lab • PR Newswire (US) • 03/29/2024 01:00:00 PM
- Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business • PR Newswire (US) • 03/28/2024 12:00:00 PM
- Labcorp to Announce First Quarter Financial Results on April 25, 2024 • PR Newswire (US) • 03/27/2024 11:00:00 AM
- Labcorp Launches pTau217 Blood Biomarker Test to Accelerate Path to Diagnosis of Alzheimer's Disease and Support Clinical Trials • PR Newswire (US) • 03/20/2024 11:00:00 AM
- Labcorp Presents New Research Demonstrating Clinical Impact of Precision Diagnostics in Guiding Biomarker-targeted Therapies for Patients with Epithelial Ovarian Cancer • PR Newswire (US) • 03/16/2024 02:29:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/11/2024 12:59:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/11/2024 12:56:14 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/07/2024 06:16:55 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/07/2024 03:34:20 PM
- Labcorp Launches Weight Loss Management Testing Solutions • PR Newswire (US) • 03/07/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 08:05:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 08:04:06 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/21/2024 09:35:11 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM